Publications en collaboration avec des chercheurs de University of North Carolina at Chapel Hill (44)

2024

  1. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)

    Seminars in Arthritis and Rheumatism, Vol. 65

2023

  1. Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling

    Arthritis Care and Research, Vol. 75, Núm. 9, pp. 1859-1870

  2. Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort

    Arthritis and Rheumatology, Vol. 75, Núm. 12, pp. 2195-2206

  3. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

    Laboratory investigation; a journal of technical methods and pathology, Vol. 103, Núm. 6, pp. 100147

  4. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 927-936

2022

  1. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the rheumatic diseases, Vol. 81, Núm. 3, pp. 370-378

  2. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 8, pp. 1143-1150

  3. Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

    Arthritis Care and Research, Vol. 74, Núm. 4, pp. 638-647

  4. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 11, pp. 1541-1548

  5. Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine

    Lupus Science and Medicine, Vol. 9, Núm. 1

2021

  1. Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications

    Arthritis Care and Research, Vol. 73, Núm. 12, pp. 1789-1795

  2. Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: Data from an international inception cohort

    Rheumatology (United Kingdom), Vol. 60, Núm. 10, pp. 4737-4747

  3. Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort

    Arthritis and Rheumatology, Vol. 73, Núm. 12, pp. 2293-2302

2020

  1. Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort

    Arthritis and Rheumatology, Vol. 72, Núm. 10, pp. 1734-1740

  2. Construction of a frailty index as a novel health measure in systemic lupus erythematosus

    Journal of Rheumatology, Vol. 47, Núm. 1, pp. 72-81

  3. Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach

    Arthritis Care and Research, Vol. 72, Núm. 12, pp. 1800-1808

  4. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis and Rheumatology, Vol. 72, Núm. 1, pp. 67-77

  5. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

    Arthritis and Rheumatology, Vol. 72, Núm. 4, pp. 658-666

  6. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 106

2019

  1. Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort

    Arthritis Care and Research, Vol. 71, Núm. 7, pp. 893-902